 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1021 - 1030 of 2154:
FDA Puts $50,000 Cap on Conflicts in Advisory Hearings
The FDA has finalized some new rules of the road for its committees of expert advisers to bolster the public’s confidence in their advice. A signi...
FDA Puts Black-Box Warning on Bowel-Cleansing Drugs
Two prescription drugs used to cleanse the bowel before a colonoscopy may cause kidney damage, the U.S. Food and Drug Administration said Thursday. Th...
FDA Puts Black-Box Warning On Bristol-Myers Imaging Drug
A drug by Bristol-Myers Squibb Co. (BMY) used to enhance the diagnosis of heart problems using ultrasound imaging machines will carry a new warning ab...
FDA puts Denver FERN laboratory on closure list
The Food and Drug Administration has indicated it will close its laboratory in Denver, according to the Sen. Ken Salazar’s office. Salazar has joined ...
FDA puts kibosh on 'healers'
Tumorex, Immune Ace, Ellagic Insurance Formula, PC Hope, Pacific Ocean Shark Cartilage, Breast Cancer Tea Formula. They are all products sold to despe...
FDA Puts Schering-Plough Under
A widely-trumpeted experimental drug for post-surgery patients may be the first martyr under a cautious Food and Drug Administration squeezed by Congr...
FDA Question on Further Cinryze Studies Results in ViroPharma Falls
ViroPharma Inc.'s shares came down by 8.5% after the U.S. Food & Drug Administration requested an additional study on the pharmaceutical company's tr...
FDA questions Alpharma's abuse-proof pain pill
Federal regulators questioned Wednesday whether Alpharma Inc. has provided enough evidence to show that its experimental morphine pill cannot be abuse...
FDA Questions Data On Amgen, J&J Drugs
The Food and Drug Administration questioned the evidence backing an important benefit of anemia drugs made by Amgen Inc. and Johnson & Johnson, in the...
FDA questions testing of J&J pneumonia antibiotic
A Johnson & Johnson antibiotic appears to be safe, government regulators said Monday, but its effectiveness in fighting pneumonia is up for debate thi... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |